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ABSTRACT 
A STUDY OF SERUM HOMOCYSTEINE LEVELS DURING NORMAL 
PREGNANCY AND PREECLAMPSIA 
INTRODUCTION: 
Homocysteine is an aminoacid produced as a by product of protein metabolism. It is a non 
proteinaminoacid resulting from the demethylation of the essential aminoacid methionine. 
50% is remethylated to methionine and 50% is transsulfurated to cystathionine, a source of 
cysteine which is aided by vit B12 and folic acid[1] Homocysteine concentration is regulated 
by genetic factor MTHFR gene mutation, nutritional factor, age and pregnancy. 
 Normal value is 5-15 micromol/lit. A study was done on changes in homocysteine levels in 
normal pregnancy [2] the results of which showed 5.6micromol/lit at 8-16 weeks, 4.3 at 20-
28 weeks and 5.5 at 36-42 weeks of gestation. In non pregnant women it was 7.9 
micromol/lit. It was concluded that serum homocysteine levels fall during pregnancy. 
Homocysteine concentration fall during pregnancy due to hemodilution, raised  GFR, 
hormonal changes and increased fetal uptake.[3] Suboptimal methylation lead to increased 
levels of homocysteine. Hyperhomocysteinemia in pregnancy causes endothelial dysfunction 
as a result of oxidative stress, ultimately  leading to vasculopathy and platelet dysfunction 
which causes pregnancy complications like PIH, recurrent pregnancy loss, IUGR, LBW, 
Placental abruption. It can also lead to congenital anomalies like cleft lip/palate and neural 
tube defects. 
Second trimester elevation of homocysteine was associated with a 3.2 fold increased risk of 
preeclampsia [4]. The present study was planned to know the serum homocysteine levels in 
normal pregnancy and preeclampsia in South Indian population and also to know the 
correlation between severity of preeclampsia  along with the effect of homocysteine levels on 
maternal and the fetal outcome. Since there is no significant variation of serum homocysteine 
levels with the mean gestational age we have chosen third trimester 
AIM AND OBJECTIVE 
 To find any correlation between serum Homocysteine level in  
preeclampsia and  normal pregnancy and to know the severity of preeclampsia whether it is 
mild/severe depending upon the elevated  Homocysteine levels. 
Study Design: Prospective case control study, observational study 
Study Population: All antenatal women with gestational age group between 28-40 weeks of 
gestation. 
Study Place: Department of Obstetrics and Gynecology, PSGIMSR. 
Sample Size: 30 normal Antental women and 30 Preeclampsia patients 
Study Duration: 1 year 
INCLUSION CRITERIA 
 All antenatal women with gestational age between 28 to 42 weeks of gestation 
EXCLUSION CRITERIA 
 Chronic hypertension/Abruptio placenta/DM /smokers/twin pregnancy/preterm 
labour/patient who are not willing to participate in the study/APL syndrome. 
MATERIALS AND METHODS 
Group 1:30 preeclampsia patients with 2 readings BP >140/90 with or without proteinuria  
Group 2: 30 normal antenatal women attending OP/admitted in ward for safe confinement 
within 28-40 weeks of gestation. 
With detail history taking and routine antenatal investigations along with PIH investigations 
in group 2 like BT,CT,APTT,PT INR, fibrinogen, urine Albumin, uric acid. Severity of 
preeclampsia was diagnosed depending upon BP >160/90 presence of proteinuria and 
immanent symptoms. Serum Homocysteine level was done in all patients 
 
SAMPLE COLLECTION METHOD: 
 5ml of venous blood is drawn from anterior cubital vein  
 Collected in EDTA Tube  
 Send to biochemistry lab within 30 minutes 
 Homocysteine levels measured by Enzyme based immunoassay 
 
 
 
RESULTS: 
The mean homocysteine value in case is 9.989±4.1 and the mean homocysteine level 
in control is 6.038±2.03 , which found to be statistically significant , that is P value  < 0.05 by 
independent t test. Elevated homocysteine levels was found in preeclampsia patients and it 
was found to be higher in severe preeclampsia when compared to nonsevere preeclampsia. 
Patients with elevated homocysteine level had increased BMI when compared to controls 
which was statistically significant.Most of the patients were primigravida. Patients with 
preecmapsia delivered by ceaserean section when compared to controls. Serum homocysteine 
level was associated with IUGR but statistically not significant due to small sample size. 
Elevated homocysteine was associated with low birth weight babies. 
CONCLUSION: 
Many prospective and retrospective studies have proven that, hyperhomocysteinemia 
causes preeclampsia in pregnancy, recurrent pregnancy loss and IUGR. The raised levels of 
homocysteine correlated with the severity of preeclampsia and eclampsia.  It is an easy test to 
perform and can be considered as a predictive marker in PIH patients. It also said that 
hyperhomocysteinemia is associated with lipid peroxidation which can cause oxidative stress 
and endothelial damage.  
Supplementation with folic acid, B vitamins, nitric oxide donors decreases the 
homocysteine levels in pregnancy and restores the endothelial function and brings down the 
maternal morbidity and mortality. Most of these studies suggest that homocysteine is a 
mediator  of endothelial damage and dysfunction which not only causes preeclampsia but 
also causes isolated IUGR and recurrent pregnancy loss in normotensive pregnant patients.  
The pathophysiology of preeclampsia and IUGR is similar  but increased levels of 
serum homocysteine is seen in preeclampsia and also has a strong correlation in preeclamptic 
toxemia. More studies and a larger scale is needed for the recommendation of this test as a 
predictive marker. 
 
 
